Login
$IKT
$1.52 -$0.07 (4.4%) Close

$IKT 8-K/A SEC Filings

Filed On Filing
02 Apr 2024 8-K/A: Departure/Election of Directors or Officers; Compensation

This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of April 1, 2024 (the “Effective Date”), by and between INHIBIKASE THERAPEUTICS, INC. (the “Company”), and Garth Lees-Rolfe (the “Employee”).

21 Mar 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support